Hormone producing organoids to halt age-related disease

JangoBio claims a scientific breakthrough in developing sustainable stem-cell based organoids for hormone restoration.

Having recently closed a $2m seed round, researchers at JangoBio’s Wisconsin laboratory announced that they have successfully created organoids to emulate the production of ovarian and testicular hormones. They claim their approach has the capacity to regenerate and replace hormone-producing tissues and reverse the natural decline of sex hormones that occurs with age.

“The development of hormone-producing organoids paves the way for use in humans and animals,” said Dr Craig Atwood, CEO. “JangoBio is rapidly moving towards testing of our organoid products in animal models.” [1]


Restoration of circulating hormone concentrations offers the benefits of preventing the symptoms of menopause and male andropause – potentially halting age-related disease and increasing the healthy lifespan of humans and animals.


 

Restoration of circulating hormone concentrations offers the benefits of preventing the symptoms of menopause and male andropause – potentially halting age-related disease and increasing the healthy lifespan of humans and animals. The JangoBio team think that implanted organoids may well be the first cell-based therapies to fully reverse hormonal decline and the associated age-related diseases, claiming that organoid-based hormone therapies are superior to traditional single hormone-based therapies, allowing restoration of all hormones produced by the ovaries and testes.

Beginning with companion animals, treatments will be administered by veterinary clinics throughout North America. The next phase of development will introduce these therapies into human clinical trials.

JangoBio utilises regenerative stem-cell based precision medicine to restore circulating hormone balance required for optimal health and Longevity.

[1] https://bit.ly/39W2YOB

Carla Heyworth
Carla is sub editor at Longevity.Technology and she's the glue that keeps the team on track and the articles rolling-out. She has an extensive background in B2B communications, events and marketing. Carla's a visual person and can often be found behind a camera or editing photos

Latest articles

Evidence for tenth hallmark of aging increases with new paper

Is ten the new nine? Additional research adds weight to the argument that extracellular matrix stiffening should be considered the tenth hallmark of aging. Since...

Help us help you: Longevity biotech survey

A new survey on translational processes and hurdles to clinical trials in Longevity biotech. We're working with two MDs: Oliver Zolman and Jian Fransen, on...

First Longevity announces first investors for current round

Some news of our own: European VC fund and a Longevity innovator participate in the First Longevity funding round. Last week we announced that Tom...

GDF15 protects from age‐related metabolic phenotypes

A recent study shows an important role for GDF15 in preventing aging-induced metabolic phenotypes by modulating systemic inflammatory responses in humans and mice. Dysfunction of...